| answer text |
<p>The National Institute for Health and Care Excellence has published technology
appraisal guidance recommending the use of methadone and buprenorphine for the management
of opioid dependence. As this was a multiple technology appraisal, multiple companies
were involved - MSD Ltd, Martindale Pharmaceuticals, Mylan, Rosemont Pharmaceuticals,
and Thornton and Ross Ltd.</p><p> </p><p>The Department does not hold data on the
number of opioid prescriptions. However, NHS Digital holds data based on prescriptions
written in the United Kingdom and dispensed in the community in England. This data
is available as prescription item level data by presentation for opioid analgesics
as listed in the British National Formulary (BNF), which is attached. We do not hold
data which identifies the manufacturer of each item dispensed.</p><p> </p><p>There
is no central National Health Service collection of information on medicines issued
and used in NHS hospitals in England.</p><p><strong> </strong></p>
|
 |
